Luxury Medical Voyages — San Francisco

FATHOMM

Beyond the horizon of conventional medicine.

Explore

The most advanced medicine is out of reach

Breakthrough gene and peptide therapies already exist — but proven treatments sit in regulatory limbo for a decade or more. Today the only path is medical tourism: long international flights, multi-day stays, language barriers, and unfamiliar clinics. Affluent clients are willing to pay for the frontier of longevity medicine, yet there is nowhere safe and seamless to go.

10+ yrs

Regulatory lag

The average FDA approval timeline for breakthrough therapies — while patients wait.

Days

Travel friction

Conventional medical tourism means international flights, extended stays, and unfamiliar systems.

$0

Safe access

No premium, medically-supervised option exists close to home for frontier protocols.

Luxury 24-hour medical voyages

Board in San Francisco, receive treatment in international waters, and return home by sunrise. Medical tourism — without the tourism.

Step One

Depart SF

Board at sunset and cruise past the Golden Gate aboard a private vessel.

🧬
Step Two

Treat Offshore

Gene therapy and peptide protocols, administered in international waters by board-certified physicians.

🌅
Step Three

Return Home

Post-treatment monitoring overnight, and back to San Francisco by morning — no passport required.

A gene therapy pipeline, at sea

FATHOMM's protocols draw on the leading edge of regenerative and longevity medicine — therapies with real clinical programs and offshore track records, delivered under physician supervision.

Follistatin
500+
Patients treated

Myostatin inhibition for lean muscle growth and fat loss. The most commercially validated longevity gene therapy.

VEGF
Phase 2
Clinical trials

Angiogenesis for vascular rejuvenation and cardiovascular optimization — a stronger clinical evidence base than most.

Klotho
2026
Anticipated launch

The anti-aging protein — 20–30% lifespan extension in animal models. The next frontier in longevity gene therapy.

BPC-157 · Healing & recovery GHK-Cu · Regeneration Thymosin Beta-4 · Immune & repair Epithalon · Telomere extension

A market at an inflection point

Longevity shifted from cosmetic anti-aging to medically-driven healthspan — the capital, the science, and the demand arrived at once.

$38–259B
Medical tourism market

Global, and growing fast.

8–23%
Annual growth

Depending on segment and scope.

$8.5B
Longevity VC

Invested in a single recent year.

The client: ages 35–65, household income $250K+, concentrated in tech hubs — San Francisco, LA, Austin, Miami. Early adopters of CGMs, NAD+ protocols, and peptide stacks, frustrated by the pace of FDA approvals and willing to pay a premium for safe access to the frontier.

"The future of medicine isn't in a waiting room."

Request an invitation

We run a limited number of voyages, by application only. Leave your details and a member of our team will contact you.

Your information stays confidential. We never share it.